Piero Parchi

Country flagItaly

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (11)

Year:

2023

Year:

2023

Year:

2023

Background Intravascular large B‐cell lymphoma (IVLBCL) is a rare extranodal lymphoma that is characterized by the selective growth of neoplastic cells in blood vessels, representing a potentially treatable cause of rapidly progressive dementia (RPD). Given its diverse clinical and instrumental presentation, it is often misdiagnosed with more common RPD causes, for example, Creutzfeldt‐Jakob disease (CJD) or vascular dementia. Methods This study presents the clinical and histopathological characteristics of four IVLBCL cases that we diagnosed post‐mortem over 20 years among over 600 brain samples received as suspected CJD cases at our prion disease reference center. Results Our patients exhibited various presenting symptoms, including behavioral disturbances, disorientation, and alertness fluctuations. The diagnostic tests performed at the time, including blood work, cerebrospinal fluid (CSF) analyses, electroencephalography, and neuroimaging, yielded nonspecific and occasionally misleading results. Consequently, the patients were repeatedly diagnosed as variably having CJD, epilepsy, vascular dementia, and encephalitis. The stored CSF samples of two patients tested negative at prion real‐time quaking‐induced conversion (RT‐QuIC), which we performed afterwards for research purposes. Neuropathological analysis revealed a differential involvement of various brain areas, with frontotemporal neocortices being the most affected. Conclusions Our results confirm the significant clinical and instrumental heterogeneity of IVLBCL. Neuropathological evidence of the preferential involvement of frontotemporal neocortices, potentially conditioning the clinical phenotype, could be relevant to reach an early diagnosis. Finally, given the therapeutic implications of its misdiagnosis with CJD, we emphasize the utility of prion RT‐QuIC as a test for ruling out CJD in these patients.

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (16)

Per Selnes

University of Oslo

NORWAY
View details

Eloy Rodriguez-Rodríguez

Instituto de Investigación Marqués de Valdecilla

SPAIN
View details

Rocco Liguori

Full Professor of Neurology

University of Bologna

ITALY
View details

Alisha Daniels

MD, MHA; Executive Research Director/Assistant Professor

Washington University in St. Louis

UNITED STATES
View details

Sabine Hellwig

Senior physican/ APL Professor

University Medical Center Freiburg

GERMANY
View details

Karen Rodrigue

Associate Professor

University of Texas at Dallas

UNITED STATES
View details

Dina Silva

Assistant Professor of Cognitive Neuroscience and Neuropsychology

Universidade do Algarve

PORTUGAL
View details

sabina capellari

Associate Professor

University of Bologna

ITALY
View details

Oskar Hansson

Full professor of Neurology

Lund University

SWEDEN
View details

Anna ladogana

Head of research

Istituto Superiore di Sanità

ITALY
View details

Andrea Mastrangelo

University of Bologna

ITALY
View details

Yvonne Freund-Levi

Karolinska Institutet

SWEDEN
View details

Samir Abu-Rumeileh

Martin Luther University Halle-Wittenberg

GERMANY
View details

Sofia Dellavalle

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori

ITALY
View details

Rik Ossenkoppele

Associate Professor in Translational Neurosience

VU Amsterdam

NETHERLANDS
View details

Patrick Oeckl

-

GERMANY
View details
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.